Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

STEPHEN ARONOFF

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1538106844
CMS profile
115152
Location
RICHARDSON, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$13,757.51

86 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 2; records 51–86 of 86 matching records. This page contains 36 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

STEPHEN ARONOFF

NPI 1538106844 · CMS profile ID 115152

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

RICHARDSON, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–86 of 86 matching records. This page contains 36 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1538106844?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
STEPHEN ARONOFF, NPI 1538106844, CMS profile ID 115152. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–86 of 86 matching records. This page contains 36 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1538106844?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). STEPHEN ARONOFF, NPI 1538106844, CMS profile ID 115152. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–86 of 86 matching records. This page contains 36 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1538106844?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
STEPHEN ARONOFF, NPI 1538106844, CMS profile ID 115152, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–86 of 86 matching records. This page contains 36 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1538106844?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

86 matching records · $13,757.51 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 86 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–86 of 86.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
SANOFI-AVENTIS U.S. LLC $19.2004/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233216761 CMS
Bayer Healthcare Pharmaceuticals Inc. $21.0904/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225450254 CMS
Novo Nordisk Inc $13.5703/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1188943358 CMS
Amgen Inc. $10.1803/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227158132 CMS
Novo Nordisk Inc $11.0103/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1188486563 CMS
ABBVIE INC. $15.8803/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201433912 CMS
Amgen Inc. $625.5003/13/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1226908416 CMS
Bayer Healthcare Pharmaceuticals Inc. $21.0903/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225450252 CMS
Sequel Med Tech, LLC $19.8103/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1243729968 CMS
Xeris Pharmaceuticals, Inc. $22.0003/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250177262 CMS
Amgen Inc. $17.5803/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228641311 CMS
Novo Nordisk Inc $19.9603/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1188862465 CMS
IBSA Pharma Inc. $15.0602/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211688786 CMS
Amgen Inc. $13.5302/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227158134 CMS
Avvisto Therapeutics, LLC $16.1502/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223114965 CMS
Neurocrine BioSciences, Inc. $16.8302/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1243037765 CMS
Verity Pharmaceuticals Inc. $20.6302/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234202273 CMS
Corcept Therapeutics $13.8802/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1214140161 CMS
Amgen Inc. $2,500.0002/11/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1226885971 CMS
Amgen Inc. $30.8002/11/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1226898249 CMS
Amgen Inc. $47.6002/11/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1226921061 CMS
Amgen Inc. $2,500.0002/11/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1226921591 CMS
Amgen Inc. $417.0002/11/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1226923260 CMS
Novo Nordisk Inc $9.4402/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189076902 CMS
Amgen Inc. $625.5002/07/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1226926636 CMS
Amgen Inc. $17.0102/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228641295 CMS
Amgen Inc. $140.2202/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228641317 CMS
Amgen Inc. $15.4902/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228641313 CMS
SANOFI-AVENTIS U.S. LLC $16.2802/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233216751 CMS
Corcept Therapeutics $35.3001/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1214140187 CMS
PFIZER INC. $20.1401/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229856768 CMS
Avvisto Therapeutics, LLC $14.7901/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223114963 CMS
Amgen Inc. $71.0201/08/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1226895675 CMS
Xeris Pharmaceuticals, Inc. $17.3301/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250177260 CMS
ABBVIE INC. $20.7001/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201433908 CMS
Avvisto Therapeutics, LLC $16.6401/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223114961 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $100,775.02 295
PY2020 $19,992.82 160
PY2021 $12,809.46 162
PY2022 $11,239.88 141
PY2023 $29,775.57 127
PY2024 $28,417.67 91
PY2025 $13,757.51 86

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2023 Recipient $285.00 1
PY2023 Principal investigator $25,112.58 19
PY2022 Recipient $285.00 1
PY2022 Principal investigator $92,176.93 70
PY2021 Principal investigator $433,985.80 227
PY2020 Recipient $192.50 1
PY2020 Principal investigator $515,673.09 168
PY2019 Principal investigator $492,004.35 220

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

20 records in PY2023

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novo Nordisk AS $4,490.10 06/23/2023 Non-covered Recipient Entity
RESEARCH INSTITUTE OF DALLAS, PA
EX9536-4388 No dispute reported 06/30/2026 1007676427
Principal investigator 1 Novo Nordisk AS $2,694.06 05/26/2023 Non-covered Recipient Entity
RESEARCH INSTITUTE OF DALLAS, PA
EX9536-4388 No dispute reported 06/30/2026 1007676415
Principal investigator 1 Novo Nordisk AS $20.10 05/12/2023 Non-covered Recipient Entity
RESEARCH INSTITUTE OF DALLAS, PA
EX9536-4388 No dispute reported 06/30/2026 1007676389
Principal investigator 1 Novo Nordisk AS $594.54 04/24/2023 Non-covered Recipient Entity
RESEARCH INSTITUTE OF DALLAS, PA
EX9536-4388 No dispute reported 06/30/2026 1007676405
Principal investigator 1 Novo Nordisk AS $397.44 04/24/2023 Non-covered Recipient Entity
RESEARCH INSTITUTE OF DALLAS, PA
NN9924-4635 No dispute reported 06/30/2026 1008118177
Principal investigator 1 Eli Lilly and Company $2,441.00 04/04/2023 Non-covered Recipient Entity
RESEARCH INSTITUTE OF DALLAS
EFFICACY AND SAFETY OF TIRZEPATIDE ONCE WEEKLY IN PARTICIPANTS WITHOUT TYPE 2 DIABETES WHO HAVE OBESITY OR ARE OVERWEIGHT WITH WEIGHT- RELATED COMORBIDITIES: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL (SURMOUNT-1) No dispute reported 06/30/2026 1038125793
Principal investigator 1 Novo Nordisk AS $70.00 03/31/2023 Non-covered Recipient Entity
RESEARCH INSTITUTE OF DALLAS, PA
NN9924-4635 No dispute reported 06/30/2026 1008311945
Principal investigator 1 Novo Nordisk AS $3,345.12 03/24/2023 Non-covered Recipient Entity
RESEARCH INSTITUTE OF DALLAS, PA
EX9536-4388 No dispute reported 06/30/2026 1007676375
Principal investigator 1 Novo Nordisk AS $788.40 03/24/2023 Non-covered Recipient Entity
RESEARCH INSTITUTE OF DALLAS, PA
NN9924-4635 No dispute reported 06/30/2026 1008311929
Principal investigator 1 Novo Nordisk AS $70.00 02/28/2023 Non-covered Recipient Entity
RESEARCH INSTITUTE OF DALLAS, PA
NN9924-4635 No dispute reported 06/30/2026 1008118203
Principal investigator 1 Novo Nordisk AS $1,797.84 02/22/2023 Non-covered Recipient Entity
RESEARCH INSTITUTE OF DALLAS, PA
EX9536-4388 No dispute reported 06/30/2026 1007676363
Recipient Eli Lilly and Company $285.00 01/31/2023 Covered Recipient Physician EFFICACY AND SAFETY OF TIRZEPATIDE ONCE WEEKLY IN PARTICIPANTS WITHOUT TYPE 2 DIABETES WHO HAVE OBESITY OR ARE OVERWEIGHT WITH WEIGHT- RELATED COMORBIDITIES: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL (SURMOUNT-1) No dispute reported 06/30/2026 1038056647
Principal investigator 1 Novo Nordisk AS $70.00 01/31/2023 Non-covered Recipient Entity
RESEARCH INSTITUTE OF DALLAS, PA
NN9924-4635 No dispute reported 06/30/2026 1008118191
Principal investigator 1 Novo Nordisk AS $9.99 01/30/2023 Non-covered Recipient Entity
RESEARCH INSTITUTE OF DALLAS, PA
NN9535-4321 No dispute reported 06/30/2026 1006741991
Principal investigator 1 Eli Lilly and Company $19.00 01/26/2023 Non-covered Recipient Entity
RESEARCH INSTITUTE OF DALLAS
EFFICACY AND SAFETY OF TIRZEPATIDE ONCE WEEKLY IN PARTICIPANTS WITHOUT TYPE 2 DIABETES WHO HAVE OBESITY OR ARE OVERWEIGHT WITH WEIGHT- RELATED COMORBIDITIES: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL (SURMOUNT-1) No dispute reported 06/30/2026 1038128285
Principal investigator 1 Eli Lilly and Company $37.50 01/26/2023 Non-covered Recipient Entity
RESEARCH INSTITUTE OF DALLAS
THE EFFECT OF TIRZEPATIDE VERSUS DULAGLUTIDE ON MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES (SURPASS CVOT) No dispute reported 06/30/2026 1038150467
Principal investigator 1 Novo Nordisk AS $2,141.82 01/25/2023 Non-covered Recipient Entity
RESEARCH INSTITUTE OF DALLAS, PA
EX9536-4388 No dispute reported 06/30/2026 1007676353
Principal investigator 1 Novo Nordisk AS $1,123.85 01/25/2023 Non-covered Recipient Entity
RESEARCH INSTITUTE OF DALLAS, PA
NN9924-4635 No dispute reported 06/30/2026 1008118163
Principal investigator 1 Novo Nordisk AS $5.82 01/23/2023 Non-covered Recipient Entity
RESEARCH INSTITUTE OF DALLAS, PA
EX9536-4388 No dispute reported 06/30/2026 1007676339
Principal investigator 1 Eli Lilly and Company $4,996.00 01/17/2023 Non-covered Recipient Entity
RESEARCH INSTITUTE OF DALLAS
THE EFFECT OF TIRZEPATIDE VERSUS DULAGLUTIDE ON MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES (SURPASS CVOT) No dispute reported 06/30/2026 1038137083